Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Zybrestat (fosbretabulin)
i
Other names:
CA4P, Combretastatin-A4, CS-A4, CA4DP
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Oncotelic
Drug class:
Tubulin polymerization inhibitor, Vascular disrupting agent, Cadherin 5 inhibitor, Cell adhesion inhibitor
Related drugs:
‹
vincristine (25)
vinorelbine tartrate (25)
vincristine liposomal (3)
PEN-221 (1)
AMXI-5001 (0)
BNC105 (0)
vinorelbine tartrate oral (0)
SB01 (0)
NSC B238865 (0)
benzosuberene (0)
OXi4503 (0)
EPC2407 (0)
CYT997 (0)
KX2-391 oral (0)
CKD-516 (0)
BAL101553 (3)
VB-111 (2)
ABT-751 (0)
AGI-101H (0)
NGR-hTNF (0)
pexastimogene devacirepvec (0)
padeliporfin (0)
vincristine (25)
vinorelbine tartrate (25)
vincristine liposomal (3)
PEN-221 (1)
AMXI-5001 (0)
BNC105 (0)
vinorelbine tartrate oral (0)
SB01 (0)
NSC B238865 (0)
benzosuberene (0)
OXi4503 (0)
EPC2407 (0)
CYT997 (0)
KX2-391 oral (0)
CKD-516 (0)
BAL101553 (3)
VB-111 (2)
ABT-751 (0)
AGI-101H (0)
NGR-hTNF (0)
pexastimogene devacirepvec (0)
padeliporfin (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer (NCT01305213)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
07/30/2019
Initiation :
03/21/2011
Primary completion :
08/20/2016
Completion :
11/03/2016
MUC16
|
Avastin (bevacizumab) • cisplatin • Beianting (bevacizumab biosimilar) • Boyounuo (bevacizumab biosimilar) • Hanbeitai (bevacizumab biosimilar) • Vasforda (bevacizumab biosimilar) • Zybrestat (fosbretabulin)
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers (NCT02132468)
Phase 2
Mateon Therapeutics
Mateon Therapeutics
Completed
Phase 2
Mateon Therapeutics
Completed
Last update posted :
12/05/2017
Initiation :
09/01/2014
Primary completion :
06/01/2016
Completion :
08/01/2016
CHGA
|
Zybrestat (fosbretabulin)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login